These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38807227)

  • 1. Implementing Canada's first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS).
    Rioux W; Taplay P; Morris-Miller L; Ghosh SM
    Harm Reduct J; 2024 May; 21(1):102. PubMed ID: 38807227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).
    Viste D; Rioux W; Cristall N; Orr T; Taplay P; Morris-Miller L; Ghosh SM
    BMC Public Health; 2023 Sep; 23(1):1869. PubMed ID: 37752527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service.
    Rioux W; Enns B; Jackson J; Quereshi H; Irvine M; Ghosh SM
    Subst Abuse Treat Prev Policy; 2023 Oct; 18(1):57. PubMed ID: 37794482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessibility gaps of physical supervised consumption sites in Canada motivating the use of overdose response technology/phone based virtual overdose response services: a retrospective cohort study.
    Mocanu V; Viste D; Rioux W; Ghosh SM
    Lancet Reg Health Am; 2024 Jun; 34():100770. PubMed ID: 38798948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual overdose monitoring services and overdose prevention technologies: Opportunities, limitations, and future directions.
    Rioux W; Marshall T; Ghosh SM
    Int J Drug Policy; 2023 Sep; 119():104121. PubMed ID: 37453373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada.
    Bardwell G; Lappalainen L
    Can J Public Health; 2021 Aug; 112(4):733-736. PubMed ID: 33782915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    ; Austin T; Boyd J
    Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
    Young S; Fairbairn N
    Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the feasibility for an overdose prevention line to support substance users who use alone.
    Ritchie K; Ghosh SM
    Harm Reduct J; 2022 Aug; 19(1):92. PubMed ID: 35986328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual overdose monitoring services/mobile overdose response services: estimated number of potentially averted drug poisoning fatality events by various telephone and digital-based overdose prevention/harm reduction services in North America.
    Rioux W; Enns B; Ghosh SM
    Front Public Health; 2023; 11():1242795. PubMed ID: 37927877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study.
    Bristowe SK; Ghosh SM; Trew M; ; Rittenbach K
    JMIR Res Protoc; 2021 May; 10(5):e20183. PubMed ID: 33978598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preference for hotline versus mobile application/countdown-based mobile overdose response services: a qualitative study.
    Rioux W; Teare A; Rider N; Jones S; Ghosh SM
    Harm Reduct J; 2024 Feb; 21(1):31. PubMed ID: 38317194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical studies of harm reduction: Overdose response in uncertain political times.
    Watson TM; Kolla G; van der Meulen E; Dodd Z
    Int J Drug Policy; 2020 Feb; 76():102615. PubMed ID: 31837567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Bed Bugs and Beyond": An ethnographic analysis of North America's first women-only supervised drug consumption site.
    Boyd J; Lavalley J; Czechaczek S; Mayer S; Kerr T; Maher L; McNeil R
    Int J Drug Policy; 2020 Apr; 78():102733. PubMed ID: 32247720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
    Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.
    Hawk KF; Vaca FE; D'Onofrio G
    Yale J Biol Med; 2015 Sep; 88(3):235-45. PubMed ID: 26339206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.